David Krag is an Oncology physician affiliated with University of Vermont. OpenAlex indexes 225 publications with 16,738 citations (h-index 54); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Surgical Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
111 Colchester Ave
Main Paviliion-Level 2
Burlington, VT 054011473
Telephone
802-656-5830Registry record last updated 8 Jul 2007.
Clinical trials
- Clinical Trial to Treat Stage IV Cancer Patients
Sponsor: Moonshot Antibodies
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
8 NIH research awards on record, funded 1994–2012 per NIH RePORTER. The latest:
- Sentinel Node Versus Axillary Dissection in Breast Cancer
University of Vermont & St Agric College
FY2012$685,471R01CA074137 - Sentinel Node Versus Axillary Dissection in Breast Cancer
University of Vermont & St Agric College
FY2011$693,246R01CA074137 - Sentinel Node Versus Axillary Dissection in Breast Cancer
University of Vermont & St Agric College
FY2010$747,145R01CA074137
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The False‐Negative Rate of Sentinel Node Biopsy in Patients with Breast Cancer: A Meta‐Analysis
World Journal of Surgery
2012 - Effect of Occult Metastases on Survival in Node-Negative Breast Cancer
New England Journal of Medicine
2011 - Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection
Journal of Surgical Oncology
2010
Similar KOLs
Other experts from the same institution or the same specialty.
David Schneider, MD
University of Vermont
Robert Althoff, MD, PhD
University of Vermont
John Helzer, MD
University of Vermont
Neil Zakai, MD
University of Vermont
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”